Abstract

Compounding Naltrexone for the Treatment of Autism

Author(s): Wynn Tom, Brunetti Sarah

Issue: Jul/Aug 2009 - Homone Replacement Therapy

Page(s): 296-299

Download in electronic PDF format for $75
  • Compounding Naltrexone for the Treatment of Autism Page 1
  • Compounding Naltrexone for the Treatment of Autism Page 2
  • Compounding Naltrexone for the Treatment of Autism Page 3
  • Compounding Naltrexone for the Treatment of Autism Page 4

Abstract

Autism is a complex disorder that affects children. Children who present with symptoms of autism require a comprehensive evaluation by a multidisciplinary team including a psychologist, neurologist, psychiatrist, speech therapist, and other professionals who diagnose children with autism spectrum disorders. Following the diagnosis, a treatment plan is developed, which in most cases involve educational and behavioral interventions and medications. The multidisciplinary team then expands to a team of professionals to treat the disorder, the team of which includes a pharmacist. Anxiety, depression, obsessive-compulsive disorder, behavioral problems, seizures, impulsivity, and hyperactivity are the main symptoms of autism that have in many cases been successfully minimized and in some cases alleviated by proper medication.

Related Keywords

  • autism spectrum disorder
  • children
  • neurotransmitters
  • opioid excess
  • beta endorphins
  • brain development
  • naltrexone hydrochloride
  • opioid antagonist
  • narcotic inhibitor
  • case reports
  • formulation

Related Categories

  • FORMULATIONS
  • MENTAL HEALTH
  • PEDIATRICS
  • CASE REPORTS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2009
Pg. 296-299
Compounding Naltrexone for the Treatment of Autism
Author(s): Wynn Tom, Brunetti Sarah
Jul/Aug 2018
Pg. 270-278
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
May/Jun 2021
Pg. 233
Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 482-485
Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars
Author(s): Harris Kylie, Wright Edward
May/Jun 2013
Pg. 235
Naltrexone Hydrochloride 50-mg Capsules
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 157-162
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Jan/Feb 2000
Pg. 17-20
Opioids: A Review of the Pharmacology
Author(s): Ford Peter R
Jan/Feb 2001
Pg. 18-19
Autism in Children
Author(s): Cave Stephanie
Nov/Dec 2005
Pg. 487-488
PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Author(s): Neurander James A
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Nov/Dec 2005
Pg. 413-420
Unlocking Autism: Is Compounding the Key?
Author(s): Vail Jane
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2023
Pg. 468-473
Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Author(s): Rodriguez Franklin, Carvalho Maria, Banov Fabiana
May/Jun 2016
Pg. 197-201
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Author(s): Sturn Kayla M, Collin Michael
Jan/Feb 2023
Pg. 6-10
Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Author(s): Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew